✦ LIBER ✦

Design of a placebo-controlled clinical trial of long-acting diltiazem and aspirin versus aspirin alone in patients receiving thrombolysis with a first acute myocardial infarction

✍ Scribed by William E. Boden; Rudy Scheldewaert; Ewan G. Walters; Anne Whitehead; D. John Coltart; Jean-Philippe Santoni; Graham Belgrave; Ian R. Starkey

Book ID: 113981854
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 558 KB
Volume: 75
Category: Article
ISSN: 0002-9149
DOI: 10.1016/s0002-9149(99)80742-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Direct comparison of aspirin plus hirudi

Direct comparison of aspirin plus hirudin aspirin plus heparin, and aspirin alone among 12,000 patients with acute myocardial infarction not receiving thrombolysis: Rationale and design of the First American Study of Infarct Survival (ASIS-1)

✍ Paul M. Ridker; Christopher J. O'Donnell; Charles H. Hennekens 📂 Article 📅 1995 🏛 Springer US 🌐 English ⚖ 632 KB

A unicenter, randomized, double-blind, p

A unicenter, randomized, double-blind, parallel-group, placebo-controlled study of Melatonin as an Adjunct in patients with acute myocaRdial Infarction undergoing primary Angioplasty: The Melatonin Adjunct in the acute myocaRdial Infarction treated with Angioplasty (MARIA) trial: Study design and rationale

✍ Alberto Dominguez-Rodriguez; Pedro Abreu-Gonzalez; Martín J. Garcia-Gonzalez; Ju 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 137 KB

Rationale and design of the Anti-Xa Ther

Rationale and design of the Anti-Xa Therapy to Lower cardiovascular events in Addition to standard therapy in Subjects with Acute Coronary Syndrome–Thrombolysis in Myocardial Infarction 51 (ATLAS-ACS 2 TIMI 51) trial: A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of rivaroxaban in subjects with acute coronary syndrome

✍ C. Michael Gibson; Jessica L. Mega; Paul Burton; Shinya Goto; Freek Verheugt; Ch 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 428 KB